KINIKSA PHARMACEUTICALS (UK), LTD.
BiotechKINIKSA PHARMACEUTICALS (UK), LTD. is a biotechnology company with 1 FDA-approved products.
KINIKSA PHARMACEUTICALS (UK), LTD.'s Key Drugs
KINIKSA PHARMACEUTICALS (UK), LTD.'s key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
KINIKSA PHARMACEUTICALS (UK), LTD.'s Recent FDA Approvals
New NDA/BLA approvals for KINIKSA PHARMACEUTICALS (UK), LTD. over the last two years — novel drugs only, excluding generics and label supplements.
KINIKSA PHARMACEUTICALS (UK), LTD.'s Therapeutic Areas
Disease areas where KINIKSA PHARMACEUTICALS (UK), LTD. has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
KINIKSA PHARMACEUTICALS (UK), LTD. Pipeline Snapshot
Active clinical trials for KINIKSA PHARMACEUTICALS (UK), LTD. across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2008-02-27
- Latest
- 2026-03-10
- Applications
- 1